Navigation Links
Pharmaxis Reports Phase II Results for Aridol in COPD

epted as an important measure in determining the prognosis of patients with COPD3 and a simple test such as Aridol to identify hyper-responsiveness and monitor the effects of treatment is needed.

"Spirometry is not a good enough indicator of disease progression in COPD patients. Major international studies have also shown that inhaled corticosteroids fail to affect lung function, as measured by spirometry, in patients with mild to moderate COPD2."

To further enhance the role of Aridol in COPD management, Pharmaxis is therefore supporting an additional, and larger, study in subjects with COPD to be run in Switzerland. In the forthcoming trial, subjects with COPD and no previous exposure to inhaled corticosteroids will be treated according to the global prescribing guidelines4 and tested with Aridol before and after three months treatment with an inhaled bronchodilator and an inhaled steroid. The Swiss trial will use Aridol and not spirometry as the principal measure of disease control. The first patient is expected to be enrolled into this study in April 2007 and the study should conclude during the first half of 2008.

There are more than 30 million COPD sufferers in the developed world. Deaths from COPD have risen by 14% in men and 185% in women between 1984 and 2000. COPD is the fourth leading cause of death in the U.S. and the only major cause of death that continues to rise.

For more details about the current trial, refer to the trial's disclosure summary below.

To find out more about Pharmaxis, go to http://www.pharmaxis.com.au

For trial information about recruitment, subjects and end points go to page3, http://www.pharmaxis.com.au/library/2007_03_14_COPD201.pdf

    1: Chest: (2003) 124, 449-458

    2: British Medical Journal (2000) 320, 1297-1303

    3: Respira
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
2. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
3. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
4. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
5. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Pharmaxis Reports Phase Results for Aridol COPD
(Date:8/27/2015)... Pa. , Aug. 27, 2015  PinnacleHealth CardioVascular Institute ... and second in the United States ... new type of stent for blockages in the main artery ... within the artery and potentially less risk for stent fracture ... is a prospective, single-arm, multicenter clinical trial of the BioMimics ...
(Date:8/27/2015)... , Aug. 27, 2015  Lightwave Logic, ... the development of Next Generation Photonic Devices ... applications in high speed fiber-optic data communications and ... Lebby has been appointed to the Company,s ... in the field of optoelectronics is widely recognized ...
(Date:8/27/2015)... 27, 2015  CytomX Therapeutics, Inc., a biopharmaceutical ... cancer, today announced that Rachel Humphrey , ... of Directors, has been appointed chief medical officer. ... and AstraZeneca, and also oversaw clinical development of ... at Bristol-Myers Squibb and the development of Nexavar ...
Breaking Medicine Technology:First Pennsylvania Patient Treated in Landmark Vascular Study 2Lightwave Logic Announces the Appointment of Optoelectronics Industry Leader, Michael Lebby, Ph.D. to its Board of Directors 2Lightwave Logic Announces the Appointment of Optoelectronics Industry Leader, Michael Lebby, Ph.D. to its Board of Directors 3Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX as Chief Medical Officer 2Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX as Chief Medical Officer 3
... Corporation (Nasdaq: OMER ), a biopharmaceutical company ... inflammation and disorders of the central nervous system, today ... call Monday afternoon, October 25, 2010 at 4:00 p.m. ... Demopulos, M.D., chairman and chief executive officer, will provide ...
... 22 Endo Pharmaceuticals (Nasdaq: ENDP ) today announced ... Healthcare Conference on Tuesday, November 2, 2010, at 2:10 p.m. EDT. ... company,s products and development programs. There will be a ... www.endo.com under the investors section. About ...
Cached Medicine Technology:Omeros to Host Conference Call Monday, October 25 at 4:00 p.m. ET To Provide Corporate Update 2
(Date:8/27/2015)... ... ... In an article published July 30th by the New York ... highlighting a security firm that is tasked with providing supplemental protection. Called the French ... with the city to provide private security when it is needed in a city ...
(Date:8/27/2015)... ... August 27, 2015 , ... On May 30th, 2015, at the Adams ... sponsor of the “Music With A Mission” benefit concert. For the past two years, ... in the underfunded school districts of Mendon and neighboring town, Quincy, IL. Organized in ...
(Date:8/27/2015)... ... August 27, 2015 , ... Infocast ... for October 27-29, 2015 in San Jose, CA. The first event dedicated ... on the void that exists where battery development and energy storage innovation are ...
(Date:8/27/2015)... ... August 27, 2015 , ... More destinations and stores are becoming pet-friendly, ... Amica Insurance is sharing some tips to help your whole family travel safely and ... travel with pets each year. Amica is sharing the following tips from the American ...
(Date:8/27/2015)... ... 27, 2015 , ... For the first time, Ninja® introduces ... Nutri Ninja® Auto-iQ Pro Complete and Nutri Ninja Auto-iQ Compact System. These two ... customization to a whole new level. This line of Nutri Ninja products is ...
Breaking Medicine News(10 mins):Health News:Article on New Orleans Security Force Highlights the Abilities and Flexibility of Private Security, says Spear Security Inc. 2Health News:Best Drug Rehabilitation Interviews Madd Hoss Jackson at the 2015 "Music With A Mission" Benefit Concert 2Health News:Infocast Hosting First Conference Dedicated to Powering Wearable Devices & the IoT 2Health News:Amica Unleashes 5 Tips for Safe Traveling with Pets 2Health News:SharkNinja's Nutri Ninja® Auto-iQ™ Pro Complete Delivers Power And Versatility In A Compact Design 2Health News:SharkNinja's Nutri Ninja® Auto-iQ™ Pro Complete Delivers Power And Versatility In A Compact Design 3Health News:SharkNinja's Nutri Ninja® Auto-iQ™ Pro Complete Delivers Power And Versatility In A Compact Design 4
... an as yet unknown reason, cancer radiotherapy can increase ... problem that is growing as more and more people ... now suggests that sustained inflammation induced by post-radiotherapy changes ... the cause. Epidemiological studies have shown that ...
... historian Nicholas Everett and Walid Saleh, a scholar of ... each been selected to receive a highly competitive New ... research. It is the first time the fellowships, ... United States. The New Directions Fellowships are ...
... whites at specialized cancer centers, research shows , MONDAY, ... cancer patients receive similar care at specialized cancer centers, ... a U.S. study has found. , The finding suggests ... previous findings of racial disparities in cancer deaths, the ...
... ... ... ... MONTREAL , March 22 /PRNewswire/ - Haemacure Corporation (TSX:HAE) announces that it has obtained authorization from the Superior Court of the Province of Québec to sell ...
... available to parents and pupils about asbestos exposure in schools. The call comes less than a month after a report by the Asbestos Training and Consultancy ... ... , ... ...
... Bakeries Across USA Join Campaign For Epilepsy Awareness , ... , , ... ... NEW YORK , March 22 This week, bakeries across ...
Cached Medicine News:Health News:Radiotherapy can cause lasting vascular disease 2Health News:University of Toronto scholars receive prestigious New Directions Fellowships 2Health News:Where Cancer Treatment Takes Place May Influence Outcome 2Health News:Court Authorizes Haemacure to Sell its Assets and Grants a Second Extension to Make a Proposal to its Creditors 2Health News:First Personal Injury on Asbestos in Schools 2Health News:Purple Cupcake Production on the Rise Nationwide 2Health News:Purple Cupcake Production on the Rise Nationwide 3
Indications For Usage: ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hours...
... T helps provide protection to the exposed airway ... extremely lightweight making it ideal for active young ... rate of heat and moisture recovery, it ensures ... HMEs and filters have ISO standard tapered ends ...
... The AlphaPette Pipettor is the #1 ... Offers accuracy, comfort, and reliability. Continuously ... volume readout sub-micrometer. Easy interchangeable ejector ... tiny hands. Adjustable rapid pipet tip ...
... Our variable volume Finnpipette ... in a high performance pipette. ... colour-coded volume range, ensures quality, ... identification of the volume range ...
Medicine Products: